BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 37248976)

  • 21. [Advances in clinical diagnosis and treatment of drug-induced liver injury in children].
    Peng XR; Chang YN; Qin T; Shang TT; Xu HM
    Zhonghua Gan Zang Bing Za Zhi; 2023 Apr; 31(4):440-444. PubMed ID: 37248985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consensus: guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in patients with nonalcoholic steatohepatitis.
    Regev A; Palmer M; Avigan MI; Dimick-Santos L; Treem WR; Marcinak JF; Seekins D; Krishna G; Anania FA; Freston JW; Lewis JH; Sanyal AJ; Chalasani N
    Aliment Pharmacol Ther; 2019 Mar; 49(6):702-713. PubMed ID: 30761572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse drug reactions and organ damage: The liver.
    Licata A
    Eur J Intern Med; 2016 Mar; 28():9-16. PubMed ID: 26827101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-induced liver injury: present and future.
    Suk KT; Kim DJ
    Clin Mol Hepatol; 2012 Sep; 18(3):249-57. PubMed ID: 23091804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.
    Björnsson ES; Bergmann OM; Björnsson HK; Kvaran RB; Olafsson S
    Gastroenterology; 2013 Jun; 144(7):1419-25, 1425.e1-3; quiz e19-20. PubMed ID: 23419359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-Induced Liver Injury.
    Hamilton LA; Collins-Yoder A; Collins RE
    AACN Adv Crit Care; 2016 Oct; 27(4):430-440. PubMed ID: 27959299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.
    Chalasani N; Fontana RJ; Bonkovsky HL; Watkins PB; Davern T; Serrano J; Yang H; Rochon J;
    Gastroenterology; 2008 Dec; 135(6):1924-34, 1934.e1-4. PubMed ID: 18955056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Prior Drug Allergies on the Risk, Clinical Features, and Outcomes of Idiosyncratic Drug-Induced Liver Injury in Adults.
    Yeboah-Korang A; Memon A; Patel N; Portocarrero-Castillo A; Osman A; Kleesattel D; Lopez C; Louissaint J; Sherman K; Fontana R
    Dig Dis Sci; 2022 Nov; 67(11):5262-5271. PubMed ID: 35122190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Approach to Drug-Induced Liver Injury from the Geriatric Perspective.
    Lee BT; Odin JA; Grewal P
    Curr Gastroenterol Rep; 2021 Apr; 23(4):6. PubMed ID: 33846832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Standardize the diagnosis and treatment of drug-induced liver injury, and strengthen clinical and translational research].
    Mao YM
    Zhonghua Gan Zang Bing Za Zhi; 2023 Apr; 31(4):337-338. PubMed ID: 37248972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [EASL clinical practice guidelines recommendations for drug-induced liver injury in 2019].
    Liu LW; Zhao XY; Jia JD
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jun; 27(6):420-423. PubMed ID: 31357756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis, management and prevention of drug-induced liver injury.
    Verma S; Kaplowitz N
    Gut; 2009 Nov; 58(11):1555-64. PubMed ID: 19834119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Idiosyncratic drug-induced liver injury: an overview.
    Hussaini SH; Farrington EA
    Expert Opin Drug Saf; 2007 Nov; 6(6):673-84. PubMed ID: 17967156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-induced liver injury: A management position paper from the Latin American Association for Study of the liver.
    Bessone F; Hernandez N; Tagle M; Arrese M; Parana R; Méndez-Sánchez N; Ridruejo E; Mendizabal M; Dagher L; Contreras F; Fassio E; Pessoa M; Brahm J; Silva M
    Ann Hepatol; 2021; 24():100321. PubMed ID: 33609753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An update on drug induced liver injury.
    Rangnekar AS; Fontana RJ
    Minerva Gastroenterol Dietol; 2011 Jun; 57(2):213-29. PubMed ID: 21587150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical management of patients with drug-induced liver injury (DILI).
    Björnsson ES
    United European Gastroenterol J; 2021 Sep; 9(7):781-786. PubMed ID: 35084797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monocyte-Derived Hepatocyte-Like Cell Test: A Novel Tool for in vitro Identification of Drug-Induced Liver Injury in Patients with Herbal or Dietary Supplements.
    Weber S; Wong GLH; Wong VWS; Benesic A; Chan HLY; Gerbes AL
    Digestion; 2021; 102(4):650-653. PubMed ID: 32690854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Evolving Profile of Idiosyncratic Drug-Induced Liver Injury.
    Fontana RJ; Bjornsson ES; Reddy R; Andrade RJ
    Clin Gastroenterol Hepatol; 2023 Jul; 21(8):2088-2099. PubMed ID: 36868489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Characteristics of Patients with Drug-induced Liver Injury.
    Yang LX; Liu CY; Zhang LL; Lai LL; Fang M; Zhang C
    Chin Med J (Engl); 2017 Jan; 130(2):160-164. PubMed ID: 28091407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of drug-induced liver injury as etiology for acute liver failure in Brazil.
    Santos G; Figueira ERR; D'Albuquerque LAC; Lisboa PB; de Almeida MD; Filgueira NA; Boin I; Porta G; da Silva RCMA; Viana CFG; Faria LC; Alvares-da-Silva MR; de Moraes ACP; Morsoletto DBG; Codes L; Paraná R
    Ann Hepatol; 2021; 23():100310. PubMed ID: 33508520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.